Predicting the Future: The Promise of New Tests for Prostate Cancer

Speaker: Dr. John Lewis
Original Date: Tuesday, July 22, 2014
 

Join Dr. John Lewis as he presents "Predicting the Future: The Promise of New Tests for Prostate Cancer."
 
Overview:
During this webinar, Dr. John Lewis will be discussing the use of biomarkers in prostate cancer diagnosis, including:

  • How biomarkers such as PSA are used today for prostate cancer management
  • How new biomarkers will allow patients and their physicians to make better treatment decisions

Speaker – Dr. John Lewis

Dr. John Lewis holds the Frank and Carla Sojonky Chair in Prostate Cancer Research at the University of Alberta. He is an Associate Professor in the Department of Oncology, a Fellow of the National Institute of Nanotechnology, and currently serves as the chair of the Alberta Prostate Cancer Research Initiative (APCaRI).  Dr. Lewis received his B.Sc. Honours in Genetics at University of Western Ontario in the Department of Genetics and a PhD in Biochemistry at the University of Victoria in 2003. He pursued post-doctoral training in Nanotechnology and Imaging at The Scripps Research Institute in La Jolla, CA. Dr. Lewis's research group utilizes real-time intravital imaging of cancer to learn about the critical steps of disease progression. They have developed several innovative nanoparticle platforms for the early detection of cancer, drug delivery, and the study of cancer invasion and metastasis. Dr. Lewis is actively involved in advocacy and public awareness programs for prostate cancer, and enjoys surfing, snowboarding and mountain biking in his spare time. 

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
 
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.

   

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More

Prostate Cancer Canada launches first national program in radioligand therapy

Toronto, June 27, 2018 – Canadian researchers are leading the future of treatment for men with advanced prostate cancer in this country, with a new Prostate Cancer Canada grant funded by the Movember Foundation.
More


Click here for news archive